Essex Bio-Technology Ltd
HKEX:1061
Essex Bio-Technology Ltd
Cost of Revenue
Essex Bio-Technology Ltd
Cost of Revenue Peer Comparison
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Essex Bio-Technology Ltd
HKEX:1061
|
Cost of Revenue
-HK$167.3m
|
CAGR 3-Years
3%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
H
|
Hbm Holdings Ltd
HKEX:2142
|
Cost of Revenue
-$2m
|
CAGR 3-Years
-65%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
N/A
|
C
|
China Regenerative Medicine International Ltd
HKEX:8158
|
Cost of Revenue
-HK$50.1m
|
CAGR 3-Years
29%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
Uni-Bio Science Group Ltd
HKEX:690
|
Cost of Revenue
-HK$91.9m
|
CAGR 3-Years
-49%
|
CAGR 5-Years
-39%
|
CAGR 10-Years
N/A
|
|
CK Life Sciences Intl (Holdings) Inc
HKEX:775
|
Cost of Revenue
-HK$3.7B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
See Also
What is Essex Bio-Technology Ltd's Cost of Revenue?
Cost of Revenue
-167.3m
HKD
Based on the financial report for Dec 31, 2023, Essex Bio-Technology Ltd's Cost of Revenue amounts to -167.3m HKD.
What is Essex Bio-Technology Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
4%
Over the last year, the Cost of Revenue growth was -30%. The average annual Cost of Revenue growth rates for Essex Bio-Technology Ltd have been 3% over the past three years , 4% over the past five years .